Levosulpiride - CAS 23672-07-3
Catalog number: 23672-07-3
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
COA:
Inquire
Targets:
Dopamine Receptor
Description:
Levosulpiride is a selective antagonist for D2 dopamine receptors used as an antipsychotic and prokinetic agent.Levosulpiride is used in the treatment of psychoses, particularly negative symptoms of schizophrenia, anxiety disorders, dysthymia, vertigo, dyspepsia, irritable bowel syndrome and premature ejaculation.
Publication citing BOC Sciences Products
1. Liquid–Liquid Equilibria for the Water (1)+ Acetic Acid (2)+ Nopol (3)+ Nopyl Acetate (4) Quaternary System at (298.15, 323.15, and 348.15) K and 85.8 kPa
2. Treatment of 17α‑ethinylestradiol, 4‑nonylphenol, and carbamazepine in wastewater using an aerobic granular sludge sequencing batch reactor
3. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat
4. Behavioral effects of toll-like receptor-4 antagonist 'eritoran'in an experimental model of depression: role of prefrontal and hippocampal neurogenesis and γ-aminobutyric acid/glutamate balance
5. Oligostilbenoids in Vitis vinifera L. Pinot Noir grape cane extract: Isolation, characterization, in vitro antioxidant capacity and anti-proliferative effect on cancer cells
6. Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition

>> More

Purity:
>98%
Synonyms:
(S)-(-)-Sulpiride; (S)(-)Sulpiride; (S) (-) Sulpiride;
MSDS:
Inquire
InChIKey:
BGRJTUBHPOOWDU-NSHDSACASA-N
InChI:
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1
Canonical SMILES:
CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
1.Herbal medicine treatment for drug-induced parkinsonism.
Shim YH1, Park JY, Choi WW, Min IK, Park SU, Jung WS, Moon SK, Park JM, Ko CN, Cho KH, Cho SY. J Altern Complement Med. 2015 May;21(5):273-80. doi: 10.1089/acm.2014.0124. Epub 2015 Apr 20.
OBJECTIVES: To evaluate the role of herbal medicine in drug-induced parkinsonism (DIP) and identify an optimal treatment approach.
2.Combination of capillary electrophoresis, molecular modeling and NMR to study the enantioselective complexation of sulpiride with double cyclodextrin systems.
Melani F1, Pasquini B2, Caprini C2, Gotti R3, Orlandini S4, Furlanetto S5. J Pharm Biomed Anal. 2015 Oct 10;114:265-71. doi: 10.1016/j.jpba.2015.05.031. Epub 2015 Jun 1.
The enantioselective complexation of sulpiride by a number of cyclodextrins (CDs) was deeply investigated by different techniques with the aim of evaluating the role of the used chiral selectors involved in the enantioseparation of the eutomer levosulpiride (S-SUL) and its dextro-isomer by capillary electrophoresis (CE). A CE method was previously developed with the aim of determining the optical purity of S-SUL and was based on the use of a dual cyclodextrin system, made by sulfated-β-cyclodextrin (SβCD) and methyl-β-cyclodextrin (MβCD). In this paper, a molecular modeling study made it possible to explain the different affinity of sulpiride enantiomers for several CDs, which had been tested during the early phase of CE method development. The potential and the gain energy of the inclusion complexes between the enantiomers and neutral and charged CDs were calculated on the minimized conformations. The calculated docking energies indicated that the most stable complexes were effectively obtained with SβCD and MβCD.
3.Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers.
Gong C1, Agbokponto JE1, Yang W1, Simpemba E1, Zheng X1, Zhang Q2, Ding L1. Acta Pharm Sin B. 2014 Oct;4(5):402-7. doi: 10.1016/j.apsb.2014.06.001. Epub 2014 Jul 3.
The main purpose of this study was to evaluate the pharmacokinetics of levosulpiride in humans after single and multiple intramuscular injections. Six males and six females received single dose of either 25 mg or 50 mg levosulpiride, or multiple doses of 25 mg every 12 h for 5 consecutive days. In the single 25 mg study, the mean peak plasma concentration (C max) was 441 ng/mL, the mean area under the concentration-time curve from 0 to 36 h (AUC0-36) was 1724 ng h/mL, and the mean elimination half-life (t 1/2) was 7.0 h. In the single 50 mg study, the mean C max was 823 ng/mL, the mean AUC0-36 was 3748 ng·h/mL, and the mean t 1/2 was 6.8 h. After multiple doses of 25 mg levosulpiride, the average plasma concentration (C av) was 136 ng/mL, the fluctuation index (DF) was 3.60, and the accumulation ratio (R) was 1.2. Levosulpiride injections appeared to be well tolerated by the subjects, and can be used for successive administration.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Dopamine Receptor Products

PD-118717
(CAS: 104229-37-0)

PD-118717 is a putative piperazinyl benzopyranone dopamine autoreceptor(DA) agonist. It has the profile of a DA autoreceptor agonist in neurochemical and neurop...

CAS 162408-66-4 GR 103691

GR 103691
(CAS: 162408-66-4)

GR 103691 is a potent dopamine D3 receptor antagonist.

CAS 19262-68-1 Dexmethylphenidate HCl

Dexmethylphenidate HCl
(CAS: 19262-68-1)

Dexmethylphenidate HCl, a synthetic sympathomimetic controlled amine with CNS stimulating properties used most commonly in the treatment of attention-deficit di...

CAS 66104-23-2 Pergolide Mesylate

Pergolide Mesylate
(CAS: 66104-23-2)

Pergolide Mesylate is an antiparkinsonian agent which functions as a dopaminergic agonist.

CAS 300561-58-4 SKF 77434 hydrobromide

SKF 77434 hydrobromide
(CAS: 300561-58-4)

SKF 77434 hydrobromide is a selective dopamine D1-like receptor partial agonist (IC50 = 19.7 and 2425 nM for binding to D1-like and D2-like receptors, respectiv...

CAS 70006-24-5 ABT724

ABT724
(CAS: 70006-24-5)

ABT-724 is a dopamine D4 agonist originated by Abbott Laboratories with EC50 value of 12.4 nM. In Dec 2007, Phase-II for Erectile dysfunction was discontinued i...

CAS 24526-64-5 Nomifensine

Nomifensine
(CAS: 24526-64-5)

Nomifensine, also called as Hoe 984 or Linamiphen, as a norepinephrine-dopamine reuptake inhibitor it is an antidepressant drug but due to increased incidence o...

CAS 866021-03-6 L-745,870 trihydrochloride

L-745,870 trihydrochloride
(CAS: 866021-03-6)

L-745,870 trihydrochloride is the trihydrochloride salt of L-745,870, which is highly selective and potent D4 dopamine receptor antagonist with Ki value of 0.51...

Chemical Structure

CAS 23672-07-3 Levosulpiride

Quick Inquiry

Verification code

Featured Items